Skip to main content
Published locations for Risk of developing dementia is similar with tofacitinib, tocilizumab, or TNFi vs. abatacept in RA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Risk of developing dementia is similar with tofacitinib, tocilizumab, or TNFi vs. abatacept in RA
User login
Username
Password
Reset your password
/content/risk-developing-dementia-similar-tofacitinib-tocilizumab-or-tnfi-vs-abatacept-ra
/rheumatology/article/254915/rheumatoid-arthritis/risk-developing-dementia-similar-tofacitinib